|
| Press Releases |
|
 |
|
| Wednesday, May 7, 2025 |
|
|
雲頂新耀宣佈耐賦康(R)獲得中國國家藥品監督管理局完全批准 全面拓展IgA腎病治療人群 |
| 今日，雲頂新耀（HKEX: 1952.HK）宣佈，其核心產品耐賦康(R)（布地奈德腸溶膠囊，NEFECON(R)）正式獲得中國國家藥品監督管理局（NMPA）完全批准。 more info >> |
|
|
云顶新耀宣布耐赋康(R)获得中国国家药品监督管理局完全批准 全面拓展IgA肾病治疗人群 |
| 今日，云顶新耀（HKEX: 1952.HK）宣布，其核心产品耐赋康(R)（布地奈德肠溶胶囊，NEFECON(R)）正式获得中国国家药品监督管理局（NMPA）完全批准。 more info >> |
|
| Tuesday, April 22, 2025 |
|
|
Everest Medicines Announces Approval of 'B' Marker Removal from Company's Stock Code by the Hong Kong Stock Exchange |
| Everest Medicines (HKEX 1952.HK, 'Everest', or the 'Company'), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that The Stock Exchange of Hong Kong Limited (the 'Stock Exchange') has approved the Company's application to remove the "B" marker from its stock short name, as the company has satisfied the requirements of the listing rules at the Stock Exchange. more info >> |
|
|
雲頂新耀「摘B」成功 盈利能力與創新價值獲雙重驗證 |
| 今日，雲頂新耀（HKEX 1952.HK）宣佈公司已獲香港聯交所批准，將「B」標記從股票代碼中移除 more info >> |
|
|
云顶新耀"摘B"成功 盈利能力与创新价值获双重验证 |
| 今日，云顶新耀（HKEX 1952.HK）宣布公司已获香港联交所批准，将"B"标记从股票代码中移除。 more info >> |
|
| Wednesday, March 19, 2025 |
|
|
雲頂新耀啟動嘉善工廠伊曲莫德生產建設項目 加速本地化供應佈局 |
| 今日，雲頂新耀宣佈正式啟動伊曲莫德（VELSIPITY(R)）位於嘉善工廠的生產建設項目，以支持該藥物的本地化生產，進一步滿足中國及亞洲市場對潰瘍性結腸炎（UC）治療的需求。該項目總投資達7000萬元，預計投產後年產能可達5000萬片，供應範圍涵蓋中國大陸、中國香港、中國澳門、中國台灣、韓國及新加坡等市場。 more info >> |
|
|
云顶新耀启动嘉善工厂伊曲莫德生产建设项目 加速本地化供应布局 |
| 今日，云顶新耀宣布正式启动伊曲莫德（VELSIPITY(R)）位于嘉善工厂的生产建设项目，以支持该药物的本地化生产，进一步满足中国及亚洲市场对溃疡性结肠炎（UC）治疗的需求。该项目总投资达7000万元，预计投产后年产能可达5000万片，供应范围涵盖中国大陆、中国香港、中国澳门、中国台湾、韩国及新加坡等市场。 more info >> |
|
| Monday, March 10, 2025 |
|
|
雲頂新耀「AI+創新藥」第一股成港股18A黑馬 |
| 近年來，AI賦能創新藥研發已成為全球生物醫藥行業的重要趨勢，尤其在mRNA疫苗領域，AI更是成為提升研發效率與精准度的核心驅動力。 more info >> |
|
|
云顶新耀"AI+创新药"第一股成港股18A黑马 |
| 近年来，AI赋能创新药研发已成为全球生物医药行业的重要趋势，尤其在mRNA疫苗领域，AI更是成为提升研发效率与精准度的核心驱动力。 more info >> |
|
| Friday, March 7, 2025 |
|
|
Everest Medicines Hits Three-Year High as AI+mRNA Pipeline Reshapes Valuation |
| Everest Medicines' stock (1952.HK) surged today, opening higher and maintaining strong momentum throughout the trading day. By market close, the stock had risen 20.12% to HK$60.6, bringing the company's total market capitalization to HK$19.791 billion. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Ondas Inc. 股東：請立即投票，以確保年度股東大會達到法定人數
May 19, 2026 04:30 HKT/SGT
|
|
|
Ondas Inc. 各位股东：请立即投票，以确保年度股东大会达到法定人数佛罗里达州西棕榈
May 19, 2026 04:30 HKT/SGT
|
|
|
Ondas Inc. Stockholders: Vote Now to Ensure Quorum for Annual Meeting
May 19, 2026 04:30 HKT/SGT
|
|
|
Paying Off Debt but Still Want to Save? Here's How to Manage Both
May 18, 2026 23:30 HKT/SGT
|
|
|
DK88 Launches New Online iGaming App for Malaysia and Singapore
May 18, 2026 22:40 HKT/SGT
|
|
|
'Hong Kong Cinema @ CANNES 2026': Hong Kong's role as a bridge between global and Asian film markets
May 18, 2026 21:52 HKT/SGT
|
|
|
Carbonverse Pioneers a New Ecosystem of "Carbon Assets + Digital Wallet + Use-to-Earn"
May 18, 2026 21:45 HKT/SGT
|
|
|
Carbonverse打造「碳资产+数字钱包+使用即挖矿」新生态
May 18, 2026 21:45 HKT/SGT
|
|
|
Tyson Fury, The Gypsy King, Joins Datavault AI as International Spokesperson to Champion Athlete Data Monetization
May 18, 2026 21:37: JST
|
|
|
「吉普賽之王」泰森·富里加入 Datavault AI 擔任國際代言人，致力推動運動員數據變現
May 18, 2026 20:37 HKT/SGT
|
|
|
“吉普赛之王”泰森·富里加盟Datavault AI，担任国际形象大使，致力于推动运动员数据变现
May 18, 2026 20:37 HKT/SGT
|
|
|
Tyson Fury, The Gypsy King, Joins Datavault AI as International Spokesperson to Champion Athlete Data Monetization
May 18, 2026 20:37 HKT/SGT
|
|
|
'Hong Kong Cinema @ CANNES 2026': Hong Kong's role as a bridge between global and Asian film markets
May 18, 2026 19:19: JST
|
|
|
Ashikaga Bank launches Fujitsu's service supporting digitalization of Inheritance Procedure
May 18, 2026 18:13 JST
|
|
|
Sharp to Exhibit at The 3rd SPEXA - Space Business Expo
May 18, 2026 17:34 JST
|
|
|
|
|
More News >> |
|
|
|
|
|
